French Sunshine Reporting: Why HCP Engagement in France Requires More Than Disclosure
Author
May Khan leads the Compliance Services team at Vector Health, a SaaS company focused on life sciences compliance. Her experience includes global transparency reporting, Sunshine Act strategy, and HCP risk monitoring. At Vector, she coordinates cross-functional teams focused on data integrity, customer service, and regulatory alignment.
Vector Health Compliance
Your Leading Partner in Global Sunshine Compliance
For companies entering the French market, sunshine reporting is only one part of the compliance picture. HCP engagement in France can involve two distinct regulatory processes: the country’s anti-gift rules and its transparency requirements. Both are governed by provisions of the French Public Health Code and can apply to interactions between healthcare professionals and companies in the pharmaceutical and medtech sectors, although their scope and requirements differ.
That distinction matters because a company may view a transfer of value primarily as a reporting event, even though the underlying engagement may also need to comply with the French anti-gift rules, including any applicable declaration or prior authorisation requirements.
French transparency reporting is not simply the French version of US Sunshine Reporting
France is sometimes described as having a French equivalent of the US Sunshine Act, but treating the two systems as interchangeable can create problems.
France’s transparency regime, commonly referred to as the French Sunshine Act, has its origins in Loi Bertrand (Loi n° 2011-2012 du 29 décembre 2011). The current requirements are set out in the French Public Health Code. The French system provides for the disclosure of agreements, remuneration and benefits involving covered healthcare professionals and other specified beneficiaries. Its reporting and publication calendar differs from that of the US Open Payments programme, so companies operating in both jurisdictions need to account for the requirements and deadlines applicable to each system.
For organisations managing global sunshine reporting, this is an important lesson. A global process can provide consistency, but it cannot mean applying one country’s reporting logic everywhere. France requires its own regulatory interpretation, data requirements and operational controls.
The cross-border question is where things become more complicated
Consider a company headquartered in the US that begins engaging French healthcare professionals for expert activities. It may not have a French legal entity. One engagement could be contracted through its US headquarters, while another could involve a UK entity.
Does the absence of a French legal entity automatically remove the French transparency obligation?
Not necessarily. The absence of a French subsidiary does not automatically rule out French transparency reporting obligations. Companies should assess whether the entities, activities and beneficiaries involved fall within the scope of the French regime before determining which disclosures are required.
This makes entity governance a critical part of HCP engagement in France. Companies cannot simply assume that their existing global reporting structure will identify the correct reporting responsibilities automatically.
Operationally, companies also need to establish the appropriate registration and access arrangements for the relevant transparency and regulatory platforms. They should confirm which legal entity is responsible for each declaration and whether separate accounts or credentials are required, rather than assuming that one consolidated group account will cover every reporting obligation.
The real challenge starts before the reporting portal
This is where French sunshine reporting becomes less about submitting data and more about managing the data lifecycle behind it.
The discussion highlighted the operational importance of reconciling anti-gift procedures, contracts and transparency data. Expense information may originate from finance systems such as Concur, while other details may need to be collected or validated manually. The specific workflow will depend on the company’s systems and internal processes.
That creates a familiar challenge for compliance teams: the information required for disclosure rarely lives in one place.
For a company beginning with a largely manual process, spreadsheets may provide an initial solution. But as engagement volumes increase, manual reconciliation can quickly become difficult to sustain. Data must be captured consistently, connected to the correct legal entity and HCP, and reconciled across the different stages of the engagement.
Why global governance still matters
France may have its own requirements, but the operational answer does not necessarily need to be completely fragmented.
The meeting discussion highlighted the value of a global sunshine reporting framework that provides consistent governance while accommodating country-specific requirements. France, the US, Belgium and Italy each have their own transparency rules, but companies can establish common principles for ownership, controls, data flows and compliance responsibilities across jurisdictions.
This approach is increasingly relevant as companies navigate national transparency requirements and industry disclosure codes across Europe. The goal is not to create one universal reporting model. It is to create one governance framework capable of accommodating different local obligations.
Ultimately, successful French sunshine reporting begins long before the disclosure deadline. Companies need to understand who is engaging the HCP, which entity is responsible, what approvals or declarations may be required, where the underlying data sits and how it will feed into the transparency reporting process.
By treating HCP engagement as a controlled, traceable process from the outset, companies can better manage French requirements while maintaining a consistent approach to global transparency reporting.
For companies entering the French market, sunshine reporting is only one part of the compliance picture. HCP engagement in France can involve two distinct regulatory processes: the country’s anti-gift rules and its transparency requirements. Both are governed by provisions of the French Public Health Code and can apply to interactions between healthcare professionals and companies in the pharmaceutical and medtech sectors, although their scope and requirements differ.
That distinction matters because a company may view a transfer of value primarily as a reporting event, even though the underlying engagement may also need to comply with the French anti-gift rules, including any applicable declaration or prior authorisation requirements.
French transparency reporting is not simply the French version of US Sunshine Reporting
France is sometimes described as having a French equivalent of the US Sunshine Act, but treating the two systems as interchangeable can create problems.
France’s transparency regime, commonly referred to as the French Sunshine Act, has its origins in Loi Bertrand (Loi n° 2011-2012 du 29 décembre 2011). The current requirements are set out in the French Public Health Code. The French system provides for the disclosure of agreements, remuneration and benefits involving covered healthcare professionals and other specified beneficiaries. Its reporting and publication calendar differs from that of the US Open Payments programme, so companies operating in both jurisdictions need to account for the requirements and deadlines applicable to each system.
For organisations managing global sunshine reporting, this is an important lesson. A global process can provide consistency, but it cannot mean applying one country’s reporting logic everywhere. France requires its own regulatory interpretation, data requirements and operational controls.
The cross-border question is where things become more complicated
Consider a company headquartered in the US that begins engaging French healthcare professionals for expert activities. It may not have a French legal entity. One engagement could be contracted through its US headquarters, while another could involve a UK entity.
Does the absence of a French legal entity automatically remove the French transparency obligation?
Not necessarily. The absence of a French subsidiary does not automatically rule out French transparency reporting obligations. Companies should assess whether the entities, activities and beneficiaries involved fall within the scope of the French regime before determining which disclosures are required.
This makes entity governance a critical part of HCP engagement in France. Companies cannot simply assume that their existing global reporting structure will identify the correct reporting responsibilities automatically.
Operationally, companies also need to establish the appropriate registration and access arrangements for the relevant transparency and regulatory platforms. They should confirm which legal entity is responsible for each declaration and whether separate accounts or credentials are required, rather than assuming that one consolidated group account will cover every reporting obligation.
The real challenge starts before the reporting portal
This is where French sunshine reporting becomes less about submitting data and more about managing the data lifecycle behind it.
The discussion highlighted the operational importance of reconciling anti-gift procedures, contracts and transparency data. Expense information may originate from finance systems such as Concur, while other details may need to be collected or validated manually. The specific workflow will depend on the company’s systems and internal processes.
That creates a familiar challenge for compliance teams: the information required for disclosure rarely lives in one place.
For a company beginning with a largely manual process, spreadsheets may provide an initial solution. But as engagement volumes increase, manual reconciliation can quickly become difficult to sustain. Data must be captured consistently, connected to the correct legal entity and HCP, and reconciled across the different stages of the engagement.
Why global governance still matters
France may have its own requirements, but the operational answer does not necessarily need to be completely fragmented.
The meeting discussion highlighted the value of a global sunshine reporting framework that provides consistent governance while accommodating country-specific requirements. France, the US, Belgium and Italy each have their own transparency rules, but companies can establish common principles for ownership, controls, data flows and compliance responsibilities across jurisdictions.
This approach is increasingly relevant as companies navigate national transparency requirements and industry disclosure codes across Europe. The goal is not to create one universal reporting model. It is to create one governance framework capable of accommodating different local obligations.
Ultimately, successful French sunshine reporting begins long before the disclosure deadline. Companies need to understand who is engaging the HCP, which entity is responsible, what approvals or declarations may be required, where the underlying data sits and how it will feed into the transparency reporting process.
By treating HCP engagement as a controlled, traceable process from the outset, companies can better manage French requirements while maintaining a consistent approach to global transparency reporting.
Author
May Khan leads the Compliance Services team at Vector Health, a SaaS company focused on life sciences compliance. Her experience includes global transparency reporting, Sunshine Act strategy, and HCP risk monitoring. At Vector, she coordinates cross-functional teams focused on data integrity, customer service, and regulatory alignment.
Vector Health Compliance
Your Leading Partner in Global Sunshine Compliance